UPDATE : Friday, June 23, 2017
상단여백
KISTI present ways to sharpen competitiveness of precision medicine
For precision medicine to take root in Korea, the nation needs to make a mo...
by Nam Doo-hyun  |  2017-06-23 13:35
라인
‘Korea needs to develop biomarkers for personalized medical services’
As the biomarker technology remains at a nascent stage in Korea, the indust...
by Nam Doo-hyun  |  2017-06-22 13:24
라인
'Bio ventures are for developing new drugs, not making cosmetics'
Bio ventures promoting cosmetic products while claiming to carry the banner...
by Nam Doo-hyun  |  2017-06-19 14:47
라인
New government set to streamline healthcare R&D projects
The Moon Jae-in administration, which is busy setting up specific strategie...
by Nam Doo-hyun  |  2017-06-15 11:05
라인
Sewon Cellontech’s cartilage-restoring device wins Europe‘s patent
Sewon Cellontech has completed its patent registration in 35 countries in E...
by Constance Williams  |  2017-06-08 17:28
라인
Government publishes report on ‘genome editing’
The Ministry of Food and Drug Safety published a report Thursday on “genome...
by Constance Williams  |  2017-06-08 15:47
라인
Celltrion’s anticancer biosimilar as effective, safe as original drug
Herzuma, Celltrion’s antibody biosimilar used to treat breast and gastric c...
by Marian Chu  |  2017-06-05 15:49
라인
Sewon Cellontech’s cartilage-restoring therapy wins Canadian patent
Sewon Cellontech세원셀론텍’s manufacturing technology of CartiZol (collagen-base...
by Constance Williams  |  2017-05-31 11:05
라인
Macrogen, KAHP to build disease-predicting big data
Macrogen, a precision medical biotechnology company, and the Korea Associat...
by Constance Williams  |  2017-05-26 16:14
라인
Patent war looming over genome editing tech
The recent U.S. ruling regarding the patent dispute over the original techn...
by Nam Doo-hyun  |  2017-05-25 14:12
라인
Medipost wins UK patent for stem-cell treatment of Alzheimer’s
Medipost (CEO Yang Yoon-sun양윤선) has obtained a patent in the United Kingdom...
by Marian Chu  |  2017-05-18 15:01
라인
Government’s bio investment focuses on new drugs
The government has funneled about 10 percent of its fiscal spending on the ...
by Nam Doo-hyun  |  2017-05-12 13:55
라인
WHO official identifies medical barriers in low-income countries
The top 10 diseases have shifted from communicable to non-communicable sick...
by Constance Williams  |  2017-04-28 10:20
라인
SillaJen to receive $4 million milestone thanks to ‘Pexa-Vec’
SillaJen신라젠, a Korean developer of bio drug, said Monday the first European...
by Constance Williams  |  2017-04-26 10:10
라인
Experts identify key trends in biosimilar market growth
Biosimilars have the potential to rake in $60 billion of revenue throughout...
by Marian Chu  |  2017-04-13 11:36
라인
BIO KOREA 2017 touches on ‘three innovations’ in healthcare
BIO KOREA 2017 opened for a three-day run at Coex, Seoul, Wednesday, during...
by Marian Chu  |  2017-04-12 18:18
라인
Insilico enters Korea to focus on skincare, wound-healing
Insilico Medicine, a big data analytics company that applies deep learning ...
by Marian Chu  |  2017-04-12 09:53
라인
Biomedicine boom sweeps domestic drugmakers
A boom to develop biomedicines is sweeping the domestic pharmaceutical comp...
by Lee Hye-seon  |  2017-04-05 18:32
라인
Sale of Remsima rises amid prescription growth in US, Europe
The sales of Remsima (Infliximab), Celltrion’s biosimilar for rheumatoid ar...
by Nam Doo-hyun  |  2017-03-30 15:43
라인
Korean firm to transfer biosimilar tech to Chinese partner
Alteogen, a Korean developer of biosimilars, said Wednesday it would transf...
by Constance Williams  |  2017-03-29 18:04
여백
여백
여백
Back to Top